Free Trial

Evogene (EVGN) SEC Filings & 10K Form

Evogene logo
$1.57 -0.08 (-4.85%)
(As of 10:54 AM ET)

Recent Evogene SEC Filings

DateFilerForm TypeView
10/15/2024
5:52 AM
Evogene (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
09/29/2024
11:15 PM
Evogene (Filer)
Form EFFECT
09/19/2024
3:15 PM
Evogene (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
09/17/2024
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
6:00 AM
Evogene (Filer)
Form D
Notice of Exempt Offering of Securities 
08/26/2024
8:30 AM
Evogene (Filer)
Form 424B5
08/23/2024
7:50 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/22/2024
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/12/2024
6:01 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2024
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
10:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2024
11:15 PM
Evogene (Filer)
Form EFFECT
03/28/2024
3:45 PM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2024
8:16 AM
Evogene (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/20/2024
8:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/01/2024
6:03 AM
Evogene (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
02/22/2024
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2024
6:01 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
7:30 PM
Evogene (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G
01/17/2024
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/09/2024
7:30 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2023
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:EVGN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners